Subtopic Deep Dive

ESKAPE Pathogens
Research Guide

What is ESKAPE Pathogens?

ESKAPE pathogens are six multidrug-resistant nosocomial bacteria—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species—responsible for most hospital-acquired infections worldwide.

These pathogens evade multiple antibiotics through intrinsic and acquired resistance mechanisms. Research spans epidemiology, virulence factors, and novel therapies, with over 20,000 papers indexed on OpenAlex. Key reviews like De Oliveira et al. (2020, 1902 citations) detail their global threat.

Curated Papers

Key Challenges

Why It Matters

ESKAPE pathogens cause 70% of hospital infections, driving 2.8 million antimicrobial-resistant cases annually in the US alone (Rice, 2008). They elevate mortality in ICU settings, with Klebsiella pneumoniae acting as a resistance shuttle (Navon-Venezia et al., 2017). Targeted surveillance and new antimicrobials are critical, as profiled in Fair and Tor (2014).

Key Research Challenges

Multidrug Resistance Mechanisms

ESKAPE pathogens employ efflux pumps, beta-lactamases, and biofilm formation to resist antibiotics. Santajit and Indrawattana (2016) catalog these in all six species. Overcoming them requires combination therapies (Mulani et al., 2019).

Nosocomial Transmission Control

Hospital spread via contaminated surfaces and ventilators complicates containment. Pendleton et al. (2013) highlight clinical relevance of environmental persistence. Surveillance gaps persist despite federal calls (Rice, 2008).

Therapeutic Development Lag

Few new antibiotics target ESKAPE since 2008, with funding shortfalls noted. Rice (2008) critiques US priorities for nosocomial pathogens. Emerging strategies like phage therapy face scalability issues (Mulani et al., 2019).

Essential Papers

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh et al. · 2010 · The Lancet Infectious Diseases · 2.9K citations

Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

Louis B. Rice · 2008 · The Journal of Infectious Diseases · 2.2K citations

The discovery of potent and safe antimicrobial agents is arguably single greatest health care advance in history. The availability of these agents rapidly reduced morbidity and mortality associat...

Antibiotics and Bacterial Resistance in the 21st Century

Richard J. Fair, Yitzhak Tor · 2014 · Perspectives in Medicinal Chemistry · 1.9K citations

Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addresse...

Antimicrobial Resistance in ESKAPE Pathogens

David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd et al. · 2020 · Clinical Microbiology Reviews · 1.9K citations

Antimicrobial-resistant ESKAPE ( E nterococcus faecium , S taphylococcus aureus , K lebsiella pneumoniae , A cinetobacter baumannii , P seudomonas aeruginosa , and E nterobacter species) pathogens ...

Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

Sirijan Santajit, Nitaya Indrawattana · 2016 · BioMed Research International · 1.6K citations

The ESKAPE pathogens ( Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter species) are the leading cause of n...

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

Mansura S. Mulani, Ekta E. Kamble, Shital N. Kumkar et al. · 2019 · Frontiers in Microbiology · 1.6K citations

The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance and virulence: <i>Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii,...

Antimicrobial Resistance: A Growing Serious Threat for Global Public Health

Md. Abdus Salam, Md. Yusuf Al-Amin, Moushumi Tabassoom Salam et al. · 2023 · Healthcare · 1.4K citations

Antibiotics are among the most important discoveries of the 20th century, having saved millions of lives from infectious diseases. Microbes have developed acquired antimicrobial resistance (AMR) to...

Reading Guide

Foundational Papers

Start with Rice (2008) for ESKAPE funding critique and nosocomial context, then Kumarasamy et al. (2010) for NDM-1 epidemiology in Klebsiella and Enterobacter, followed by Fair and Tor (2014) for 21st-century resistance profiles.

Recent Advances

De Oliveira et al. (2020) for updated mechanisms across all ESKAPE; Navon-Venezia et al. (2017) on Klebsiella resistome; Mancuso et al. (2021) on critical pathogens.

Core Methods

Epidemiological surveillance (Kumarasamy 2010), genomic resistome mapping (Navon-Venezia 2017), and in vitro biofilm assays (Santajit 2016) form core techniques.

How PapersFlow Helps You Research ESKAPE Pathogens

Discover & Search

Research Agent uses searchPapers and exaSearch to find ESKAPE reviews like De Oliveira et al. (2020), then citationGraph reveals 1,900+ downstream papers on Klebsiella resistance, while findSimilarPapers uncovers related works like Santajit and Indrawattana (2016).

Analyze & Verify

Analysis Agent applies readPaperContent to extract resistance mechanisms from Kumarasamy et al. (2010), verifies claims with CoVe against Rice (2008), and runs PythonAnalysis on citation data for trends using pandas, earning GRADE A for epidemiological evidence.

Synthesize & Write

Synthesis Agent detects gaps in ESKAPE funding post-Rice (2008), flags contradictions between Fair and Tor (2014) profiles and recent data, then Writing Agent uses latexEditText, latexSyncCitations for De Oliveira et al. (2020), and latexCompile for a review manuscript with exportMermaid diagrams of resistance pathways.

Use Cases

"Analyze resistance trends in Pseudomonas aeruginosa from 2010-2023 ESKAPE papers"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas time-series plot of citations from Poole 2011 and De Oliveira 2020) → matplotlib graph of carbapenem resistance rise.

"Draft LaTeX review on Klebsiella pneumoniae as ESKAPE resistance shuttle"

Synthesis Agent → gap detection (Navon-Venezia 2017) → Writing Agent → latexEditText + latexSyncCitations (10 ESKAPE papers) → latexCompile → PDF with resistance network diagram.

"Find GitHub repos with ESKAPE genomic data analysis code"

Research Agent → paperExtractUrls (Santajit 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified scripts for beta-lactamase sequence analysis.

Automated Workflows

Deep Research workflow scans 50+ ESKAPE papers via searchPapers → citationGraph → structured report on resistance evolution from Rice (2008) to De Oliveira (2020). DeepScan applies 7-step CoVe to verify Mulani et al. (2019) strategies against Pendleton et al. (2013). Theorizer generates hypotheses on phage synergies from gap detection in Fair and Tor (2014).

Try Doxa for ESKAPE Pathogens Research

Frequently Asked Questions

What defines ESKAPE pathogens?

ESKAPE acronyms Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species, prioritized by Infectious Diseases Society for resistance (Pendleton et al., 2013).

What are main resistance methods in ESKAPE?

Efflux pumps, enzymatic degradation, and target modification dominate; Santajit and Indrawattana (2016) detail mechanisms across all six pathogens.

Which are key ESKAPE papers?

Foundational: Rice (2008, 2239 citations) on funding gaps; Kumarasamy et al. (2010, 2887 citations) on NDM-1 emergence; recent: De Oliveira et al. (2020, 1902 citations) comprehensive review.

What open problems exist in ESKAPE research?

New antibiotic pipelines lag, hospital transmission persists, and species-specific therapies underexplored; Mulani et al. (2019) call for phage and nanoparticle strategies.